{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:49:35Z","timestamp":1762253375308,"version":"3.41.2"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Canadian Cancer Society Research Institute Grant","award":["703058"],"award-info":[{"award-number":["703058"]}]},{"DOI":"10.13039\/501100020903","name":"Peter Gilgan Foundation","doi-asserted-by":"crossref","award":["Tour de Bleu"],"award-info":[{"award-number":["Tour de Bleu"]}],"id":[{"id":"10.13039\/501100020903","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1136\/ijgc-2019-001141","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T14:56:02Z","timestamp":1588258562000},"page":"825-830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among BRCA1 and BRCA2 mutation carriers"],"prefix":"10.1016","volume":"30","author":[{"given":"Joanne","family":"Kotsopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Karlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Gronwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pal","family":"Moller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Tung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Zakalik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D","family":"Foulkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L","family":"Neuhausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Lubinksi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A","family":"Narod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2019-001141_bb0010","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-001141_bb0015","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glx026","article-title":"Bilateral oophorectomy and accelerated aging: cause or effect?","author":"Rocca","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1136\/ijgc-2019-001141_bb0020","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"journal-title":"Genetic\/familial high-risk assessment: breast and ovarian [Internet]","year":"2019","author":"National Cancer Comprehensive Network (NCCN)","key":"10.1136\/ijgc-2019-001141_bb0025"},{"key":"10.1136\/ijgc-2019-001141_bb0030","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1136\/ijgc-2019-001141_bb0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ygyno.2018.05.011","article-title":"Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation","volume":"150","author":"Kotsopoulos","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001141_bb0040","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/cncr.31211","article-title":"Peritoneal carcinomatosis after risk-reducing surgery in BRCA1\/2 mutation carriers","volume":"124","author":"Harmsen","year":"2018","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2019-001141_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00058","article-title":"Genetic evidence for early peritoneal spreading in pelvic high-grade serous cancer","volume":"8","author":"Chien","year":"2018","journal-title":"Front Oncol"},{"key":"10.1136\/ijgc-2019-001141_bb0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ygyno.2015.06.014","article-title":"Cancer precursor lesions in the BRCA population at the time of prophylactic salpingo-oophorectomy: accuracy of assessment and potential surrogate marker for prevention","volume":"138","author":"Lheureux","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001141_bb0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001141_bb0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygyno.2014.01.018","article-title":"Risk reducing salpingo-oophorectomy for BRCA mutation carriers: twenty years later","volume":"132","author":"Powell","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001141_bb0065","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1200\/JCO.2013.54.1987","article-title":"Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199","volume":"32","author":"Sherman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-001141_bb0070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2016.08.336","article-title":"Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers","volume":"143","author":"Zakhour","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001141_bb0075","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jogc.2016.12.005","article-title":"No. 344-Opportunistic salpingectomy and other methods of risk reduction for ovarian\/fallopian tube\/peritoneal cancer in the general population","volume":"39","author":"Salvador","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1136\/ijgc-2019-001141_bb0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrclinonc.2015.224","article-title":"Can advanced-stage ovarian cancer be cured?","volume":"13","author":"Narod","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1136\/ijgc-2019-001141_bb0085","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/cncr.22603","article-title":"Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation","volume":"109","author":"Laki","year":"2007","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2019-001141_bb0090","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2012.07.021","article-title":"Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens","volume":"49","author":"Reitsma","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2019-001141_bb0095","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2013.01.029","article-title":"Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy","volume":"129","author":"Powell","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001141_bb0100","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2013.12.009","article-title":"Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations","volume":"132","author":"Conner","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001141_bb0105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jama.2017.21421","article-title":"Screening for ovarian cancer: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"319","author":"Henderson","year":"2018","journal-title":"JAMA"},{"key":"10.1136\/ijgc-2019-001141_bb0110","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ygyno.2019.08.034","article-title":"A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy","volume":"155","author":"Gronwald","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001141_bb0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ygyno.2015.11.009","article-title":"Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status","volume":"140","author":"Kotsopoulos","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001141_bb0120","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","article-title":"Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA)","volume":"21","author":"Mavaddat","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1136\/ijgc-2019-001141_bb0125","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/modpathol.2009.64","article-title":"Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria","volume":"22","author":"Semmel","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1136\/ijgc-2019-001141_bb0130","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/PAS.0b013e3181868904","article-title":"Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?","volume":"33","author":"Roh","year":"2009","journal-title":"Am J Surg Pathol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24001543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24001543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2019-001141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:37:49Z","timestamp":1753223869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24001543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1048891X24001543"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2019-001141","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among BRCA1 and BRCA2 mutation carriers","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2019-001141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}